Fundraising Fox

Jennifer Cochran

Investor

Co-Founder and Chief Scientific Advisor at Red Tree Venture

Stanford / Bay Area

About

Co-founder and Chief Scientific Advisor of Red Tree and a Stanford bioengineering professor who chaired the department from 2017-2022. A serial entrepreneur who founded companies including xCella Biosciences and Combangio, she holds a Ph.D. in Biological Chemistry from MIT. Also serves as Scientific Advisory Board Chair (Oncology).

Contact· self-published, not guessed

Invests in

Biotech

Investments

Board seats

Biograph 55Biograph55EBVioExcellergy TherapeuticsKivu BioscienceOmniAbRevel PharmaceuticalsRondo Therapeutics

Investor

CombangioPhotinia BiosciencesThreefold TherapeuticsTwoStep TherapeuticsxCella Biosciences

Per the firm's website.

Colleagues at Red Tree Venture

Frequently asked questions

Who is Jennifer Cochran?
Co-founder and Chief Scientific Advisor of Red Tree and a Stanford bioengineering professor who chaired the department from 2017-2022. A serial entrepreneur who founded companies including xCella Biosciences and Combangio, she holds a Ph.D. in Biological Chemistry from MIT. Also serves as Scientific Advisory Board Chair (Oncology).
Where does Jennifer Cochran work?
Jennifer Cochran is Co-Founder and Chief Scientific Advisor at Red Tree Venture.
What does Jennifer Cochran invest in?
Jennifer Cochran invests in Biotech.
What boards does Jennifer Cochran sit on?
Jennifer Cochran holds tracked board seats at Biograph 55, Biograph55, EBVio, Excellergy Therapeutics, Kivu Bioscience, OmniAb, Revel Pharmaceuticals, Rondo Therapeutics.
What companies has Jennifer Cochran invested in?
Investments tracked here include Combangio, Photinia Biosciences, Threefold Therapeutics, TwoStep Therapeutics, xCella Biosciences.